Screener
Beta Bionics BBNX Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Beta Bionics in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Total assets | $292,387 | $328,743 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $5,351 | $4,998 |
| Accrued expenses and other current liabilities | 17,194 | 22,431 |
| Operating lease liabilities | 1,591 | 1,938 |
| Deferred revenue | 1,881 | 1,557 |
| Total current liabilities | 26,017 | 30,924 |
Item 1. Financial Statements.
FAQ
- What is Beta Bionics's accounts payable?
- Beta Bionics (BBNX) reported accounts payable of $5.35M in Q2 2026.
- How has Beta Bionics's accounts payable changed year-over-year?
- Beta Bionics's accounts payable increased by 56.3% year-over-year, from $3.42M to $5.35M.
- What is the long-term trend for Beta Bionics's accounts payable?
- Over 2 years (2023 to 2025), Beta Bionics's accounts payable has grown at a 209.7% compound annual growth rate (CAGR), from $1.7M to $16.34M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Beta Bionics's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude